DexCom, Inc.
DXCM
$61.14
$1.813.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.05% | 13.12% | 21.64% | 15.21% | 12.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.05% | 13.12% | 21.64% | 15.21% | 12.49% |
| Cost of Revenue | -1.21% | 2.01% | 19.36% | 24.02% | 24.48% |
| Gross Profit | 27.39% | 20.88% | 23.17% | 9.91% | 4.82% |
| SG&A Expenses | 12.77% | -1.80% | 8.16% | -1.41% | -2.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.80% | 1.30% | 14.79% | 11.60% | 10.05% |
| Operating Income | 90.95% | 70.99% | 59.54% | 34.56% | 32.25% |
| Income Before Tax | 74.66% | 61.24% | 98.59% | 28.38% | 16.45% |
| Income Tax Expenses | 43.15% | 23.15% | 60.05% | 38.37% | 451.80% |
| Earnings from Continuing Operations | 89.28% | 76.20% | 110.85% | 25.30% | -28.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 89.28% | 76.20% | 110.85% | 25.30% | -28.01% |
| EBIT | 90.95% | 70.99% | 59.54% | 34.56% | 32.25% |
| EBITDA | 66.44% | 57.36% | 47.66% | 31.18% | 26.11% |
| EPS Basic | 92.21% | 77.96% | 112.47% | 27.57% | -28.17% |
| Normalized Basic EPS | 72.68% | 62.88% | 100.14% | 30.71% | 19.37% |
| EPS Diluted | 92.21% | 77.97% | 109.87% | 27.45% | -25.82% |
| Normalized Diluted EPS | 76.02% | 64.40% | 99.96% | 31.11% | 22.35% |
| Average Basic Shares Outstanding | -1.53% | -1.00% | -0.79% | -1.78% | 0.23% |
| Average Diluted Shares Outstanding | -3.41% | -1.92% | -0.68% | -2.06% | -2.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |